Bausch Health Companies Inc. Proceeds from Long-Term Debt Issued
Bausch Health Companies Inc. (BHC) reported Proceeds from Long-Term Debt Issued of $2.89 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2026-07-30
- Bausch Health Companies Inc. proceeds from issuance of long-term debt for the quarter ending 2026-06-30 was $84.00M, a 99.19% decline year-over-year.
- Bausch Health Companies Inc. proceeds from issuance of long-term debt for the quarter ending 2026-03-31 was $2.80B, a 5504.00% increase year-over-year.
- Bausch Health Companies Inc. proceeds from issuance of long-term debt for the quarter ending 2025-12-31 was $133.00M, a 73.72% decline year-over-year.
- Bausch Health Companies Inc. proceeds from issuance of long-term debt for the quarter ending 2025-09-30 was -$1.00M.
- Bausch Health Companies Inc. proceeds from issuance of long-term debt for fiscal 2025 was $10.55B, a 1496.67% increase from fiscal 2024.
- Bausch Health Companies Inc. proceeds from issuance of long-term debt for fiscal 2024 was $661.00M, a 79.91% decline from fiscal 2023.
- Bausch Health Companies Inc. proceeds from issuance of long-term debt for fiscal 2023 was $3.29B, a 51.86% decline from fiscal 2022.
- Bausch Health Companies Inc. proceeds from issuance of long-term debt for fiscal 2022 was $6.84B, a 225.52% increase from fiscal 2021.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 3 month as first filed | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 6 month as first filed | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 9 month as first filed | Proceeds from Issuance of Long-term Debt 12 month | Proceeds from Issuance of Long-term Debt 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $84.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $2.89B 10-Q · filed 2026-07-30 | $3.02B derived: sum of 3 quarters · filed 2026-07-30 | $3.02B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $2.80B 10-Q · filed 2026-04-30 | $2.94B derived: sum of 2 quarters · filed 2026-04-30 | $2.93B derived: sum of 3 quarters · filed 2026-04-30 | $13.31B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $133.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $132.00M derived: sum of 2 quarters · filed 2026-02-19 | $10.50B derived: sum of 3 quarters · filed 2026-07-30 | $10.55B 10-K · filed 2026-02-19 | ||||
| 2025-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $10.37B derived: sum of 2 quarters · filed 2026-07-30 | $10.42B 10-Q · filed 2025-10-30 | $10.93B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $10.37B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $10.42B 10-Q · filed 2026-07-30 | $10.93B derived: sum of 3 quarters · filed 2026-07-30 | $10.93B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $50.00M 10-Q · filed 2026-04-30 | $556.00M derived: sum of 2 quarters · filed 2026-04-30 | $556.00M derived: sum of 3 quarters · filed 2026-04-30 | $636.00M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | $506.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $506.00M derived: sum of 2 quarters · filed 2026-02-19 | $586.00M derived: sum of 3 quarters · filed 2026-02-19 | $661.00M 10-K · filed 2026-02-19 | ||||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $80.00M derived: sum of 2 quarters · filed 2025-10-30 | $155.00M 10-Q · filed 2025-10-30 | $301.00M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-06-30 | $80.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $155.00M 10-Q · filed 2025-07-31 | $301.00M derived: sum of 3 quarters · filed 2026-02-19 | $2.99B derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-03-31 | $75.00M 10-Q · filed 2025-05-01 | $221.00M derived: sum of 2 quarters · filed 2026-02-19 | $2.91B derived: sum of 3 quarters · filed 2026-02-19 | $3.21B derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2023-12-31 | $146.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $2.84B derived: sum of 2 quarters · filed 2026-02-19 | $3.14B derived: sum of 3 quarters · filed 2026-02-19 | $3.29B 10-K · filed 2026-02-19 | ||||
| 2023-09-30 | $2.69B derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $2.99B derived: sum of 2 quarters · filed 2024-10-31 | $3.15B 10-Q · filed 2024-10-31 | $3.50B derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-06-30 | $300.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $455.00M 10-Q · filed 2024-08-01 | $810.00M derived: sum of 3 quarters · filed 2025-02-20 | $971.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-03-31 | $155.00M 10-Q · filed 2024-05-02 | $510.00M derived: sum of 2 quarters · filed 2025-02-20 | $671.00M derived: sum of 3 quarters · filed 2025-02-20 | $6.00B derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2022-12-31 | $355.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $516.00M derived: sum of 2 quarters · filed 2025-02-20 | $5.85B derived: sum of 3 quarters · filed 2025-02-20 | $6.84B 10-K · filed 2025-02-20 | ||||
| 2022-09-30 | $161.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $5.50B derived: sum of 2 quarters · filed 2023-11-02 | $6.48B 10-Q · filed 2023-11-02 | $7.00B derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-06-30 | $5.33B derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $6.32B 10-Q · filed 2023-08-03 | $6.84B derived: sum of 3 quarters · filed 2024-02-22 | $6.84B derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-03-31 | $986.00M 10-Q · filed 2023-05-04 | $1.51B derived: sum of 2 quarters · filed 2024-02-22 | $1.51B derived: sum of 3 quarters · filed 2024-02-22 | $3.09B derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | $524.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $521.00M derived: sum of 2 quarters · filed 2024-02-22 | $2.10B derived: sum of 3 quarters · filed 2024-02-22 | $2.10B 10-K · filed 2024-02-22 | ||||
| 2021-09-30 | -$3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $1.58B derived: sum of 2 quarters · filed 2022-11-03 | $1.58B 10-Q · filed 2022-11-03 | $3.56B derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-30 | $1.58B derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.58B 10-Q · filed 2022-08-09 | $3.56B derived: sum of 3 quarters · filed 2023-02-23 | $3.56B derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-31 | -$3.00M 10-Q · filed 2022-05-10 | $1.98B derived: sum of 2 quarters · filed 2023-02-23 | $1.98B derived: sum of 3 quarters · filed 2023-02-23 | $3.46B derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | $1.98B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $1.98B derived: sum of 2 quarters · filed 2023-02-23 | $3.46B derived: sum of 3 quarters · filed 2023-02-23 | $3.46B 10-K · filed 2023-02-23 | ||||
| 2020-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $1.48B derived: sum of 2 quarters · filed 2021-11-02 | $1.48B 10-Q · filed 2021-11-02 | $4.20B derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-06-30 | $1.48B derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $1.48B 10-Q · filed 2021-08-03 | $4.20B derived: sum of 3 quarters · filed 2022-05-11 | $4.19B derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-03-31 | -$3.00M 10-Q · filed 2021-05-04 | $2.72B derived: sum of 2 quarters · filed 2022-05-11 | $2.71B derived: sum of 3 quarters · filed 2022-05-11 | $4.44B derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2019-12-31 | $2.72B derived: 8-K 12 month − 10-Q 9 month · filed 2022-05-11 | $2.72B derived: sum of 2 quarters · filed 2022-05-11 | $4.45B derived: sum of 3 quarters · filed 2022-05-11 | $5.96B 8-K · filed 2022-05-11 | ||||
| 2019-09-30 | -$5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | $1.72B derived: sum of 2 quarters · filed 2020-11-03 | $3.24B 10-Q · filed 2020-11-03 | $4.71B derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-06-30 | $1.73B derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $3.24B 10-Q · filed 2020-08-06 | $4.72B derived: sum of 3 quarters · filed 2021-05-04 | $4.71B derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-03-31 | $1.51B 10-Q · filed 2020-05-07 | $2.99B derived: sum of 2 quarters · filed 2021-05-04 | $2.98B derived: sum of 3 quarters · filed 2021-05-04 | $8.98B derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2018-12-31 | $1.47B derived: 8-K 12 month − 10-Q 9 month · filed 2021-05-04 | $1.47B derived: sum of 2 quarters · filed 2021-05-04 | $7.46B derived: sum of 3 quarters · filed 2021-05-04 | $8.94B 8-K · filed 2021-05-04 | ||||
| 2018-09-30 | -$3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $5.99B derived: sum of 2 quarters · filed 2019-11-04 | $7.47B 10-Q · filed 2019-11-04 | $10.66B derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-06-30 | $5.99B derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $7.47B 10-Q · filed 2019-08-06 | $10.67B derived: sum of 3 quarters · filed 2020-02-19 | $10.67B derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-03-31 | $1.48B 10-Q · filed 2019-05-06 | $4.67B derived: sum of 2 quarters · filed 2020-02-19 | $4.67B derived: sum of 3 quarters · filed 2020-02-19 | $4.67B derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2017-12-31 | $3.19B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $3.19B derived: sum of 2 quarters · filed 2020-02-19 | $3.19B derived: sum of 3 quarters · filed 2020-02-19 | $9.42B 10-K · filed 2020-02-19 | ||||
| 2017-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$3.00M derived: sum of 2 quarters · filed 2018-11-06 | $6.23B 10-Q · filed 2018-11-06 | $6.23B derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-06-30 | -$2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $6.23B 10-Q · filed 2018-08-07 | $6.23B derived: sum of 3 quarters · filed 2019-02-20 | $6.23B derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-03-31 | $6.23B 10-Q · filed 2018-05-08 | $6.23B derived: sum of 2 quarters · filed 2019-02-20 | $6.23B derived: sum of 3 quarters · filed 2019-02-20 | $6.23B derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $0.00 derived: sum of 2 quarters · filed 2019-02-20 | $0.00 derived: sum of 3 quarters · filed 2019-02-20 | $1.22B 10-K · filed 2019-02-20 | ||||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $0.00 derived: sum of 2 quarters · filed 2017-11-07 | $1.22B 10-Q · filed 2017-11-07 | $1.22B 10-Q · filed 2016-11-09 | $2.11B derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $1.22B 10-Q · filed 2017-08-08 | $2.11B derived: sum of 3 quarters · filed 2018-08-10 | $2.11B derived: sum of 4 quarters · filed 2018-08-10 | ||||
| 2016-03-31 | $1.22B 10-Q · filed 2017-05-09 | $2.11B derived: sum of 2 quarters · filed 2018-08-10 | $2.11B derived: sum of 3 quarters · filed 2018-08-10 | $7.03B derived: sum of 4 quarters · filed 2018-08-10 | ||||
| 2015-12-31 | $891.20M derived: 8-K 12 month − 10-Q 9 month · filed 2018-08-10 | $891.20M derived: sum of 2 quarters · filed 2018-08-10 | $5.81B derived: sum of 3 quarters · filed 2018-08-10 | $17.82B 8-K · filed 2018-08-10 | $17.82B 10-K · filed 2016-04-29 | |||
| 2015-09-30 | $0.00 10-Q · filed 2015-10-26 | $4.92B derived: sum of 2 quarters · filed 2015-10-26 | $16.93B 10-Q · filed 2016-11-09 | $17.59B derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | $4.92B 10-Q · filed 2015-07-28 | $16.93B 10-Q · filed 2016-08-09 | $17.59B derived: sum of 3 quarters · filed 2017-03-01 | $18.14B derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | $12.00B 10-Q · filed 2016-06-07 | $12.00B 10-Q · filed 2015-04-30 | $12.67B derived: sum of 2 quarters · filed 2017-03-01 | $13.22B derived: sum of 3 quarters · filed 2017-03-01 | $13.27B derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2014-12-31 | $666.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $1.22B derived: sum of 2 quarters · filed 2017-03-01 | $1.27B derived: sum of 3 quarters · filed 2017-03-01 | $1.63B 10-K · filed 2017-03-01 | $1.63B 10-K · filed 2015-02-25 | |||
| 2014-09-30 | $555.00M 10-Q · filed 2015-10-26 | $604.30M derived: sum of 2 quarters · filed 2015-10-26 | $963.40M 10-Q · filed 2015-10-26 | $965.60M 10-Q · filed 2014-10-24 | $1.85B derived: sum of 4 quarters · filed 2016-04-29 | |||
| 2014-06-30 | $49.30M 10-Q · filed 2015-07-28 | $50.00M 10-Q · filed 2014-08-01 | $408.40M 10-Q · filed 2015-07-28 | $410.60M 10-Q · filed 2014-08-01 | $1.29B derived: sum of 3 quarters · filed 2016-04-29 | $8.46B derived: sum of 4 quarters · filed 2016-04-29 | ||
| 2014-03-31 | $360.60M 10-Q · filed 2015-04-30 | $1.24B derived: sum of 2 quarters · filed 2016-04-29 | $8.41B derived: sum of 3 quarters · filed 2016-04-29 | $8.75B derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2013-12-31 | $880.30M derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | $8.05B derived: sum of 2 quarters · filed 2016-04-29 | $8.39B derived: sum of 3 quarters · filed 2016-04-29 | $8.39B 10-K · filed 2016-04-29 | $8.44B 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $7.17B 10-Q · filed 2014-10-24 | $7.17B 10-Q · filed 2013-11-01 | $7.51B derived: sum of 2 quarters · filed 2014-10-24 | $7.51B 10-Q · filed 2014-10-24 | $7.51B 10-Q · filed 2013-11-01 | $12.10B derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-06-30 | $340.00M 10-Q · filed 2014-08-01 | $340.00M 10-Q · filed 2014-08-01 | $4.94B derived: sum of 3 quarters · filed 2015-02-25 | $5.06B derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-09 | $4.60B derived: sum of 2 quarters · filed 2015-02-25 | $4.72B derived: sum of 3 quarters · filed 2015-02-25 | $5.36B derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2012-12-31 | $4.60B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $4.72B derived: sum of 2 quarters · filed 2015-02-25 | $5.36B derived: sum of 3 quarters · filed 2015-02-25 | $6.01B 10-K · filed 2015-02-25 | $6.01B 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $122.30M 10-Q · filed 2013-11-01 | $763.06M derived: sum of 2 quarters · filed 2013-11-01 | $1.41B 10-Q · filed 2013-11-01 | $3.87B derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-06-30 | $640.77M 10-Q · filed 2013-08-07 | $1.29B 10-Q · filed 2013-08-07 | $3.75B derived: sum of 3 quarters · filed 2014-02-28 | $4.44B derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-03-31 | $645.64M 10-Q · filed 2013-05-03 | $3.10B derived: sum of 2 quarters · filed 2014-02-28 | $3.79B derived: sum of 3 quarters · filed 2014-02-28 | $3.89B derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | $2.46B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $3.15B derived: sum of 2 quarters · filed 2014-02-28 | $3.25B derived: sum of 3 quarters · filed 2014-02-28 | $5.39B 10-K · filed 2014-02-28 | ||||
| 2011-09-30 | $690.00M 10-Q · filed 2012-11-05 | $790.00M derived: sum of 2 quarters · filed 2012-11-05 | $2.93B 10-Q · filed 2012-11-05 | $2.14B 10-Q · filed 2011-11-04 | ||||
| 2011-06-30 | $100.00M 10-Q · filed 2012-08-03 | $2.24B 10-Q · filed 2012-08-03 | $2.14B 10-Q · filed 2011-08-08 | |||||
| 2011-03-31 | $2.14B 10-Q · filed 2012-05-04 | |||||||
| 2010-12-31 | $992.40M 10-K · filed 2013-02-28 | |||||||
| 2009-12-31 | $350.00M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |